Novo Nordisk A/S sell Biotechhunter
Start price
06.08.20
/
50%
€53.79
Target price
04.11.21
-
Performance (%)
36.51%
End price
15.07.21
€73.43
Summary
This prediction ended on 15.07.21 with a price of €73.43. The SELL prediction by Biotechhunter for Novo Nordisk A/S was trending in the completely wrong direction and closed with a performance of 36.51%. A total of €6.29 was paid as dividends for this prediction. Biotechhunter has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S | - | - | - | - |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
Comments by Biotechhunter for this prediction
In the thread Novo Nordisk A/S diskutieren
Sell Novo Nordisk A/S